Renal vein thrombosis
ICD-10 I82.3 · ICD-11 BD71.2

Treatment of Renal Vein Thrombosis with Proximal Deep Vein Thrombosis (Popliteal, Femoral, or Iliac Veins)

Renal vein thrombosis presenting alongside proximal deep vein thrombosis — thrombus involving the popliteal, femoral, or iliac veins — represents a clinically significant venous thromboembolic situation that requires prompt, structured management.

Clinical Scenario
Proximal DVT is defined as thrombus in the popliteal, femoral, or iliac veins. This anatomical location carries meaningful risk and informs the treatment strategy, including for asymptomatic or incidentally detected presentations.
Treatment Approach (Partial Overview)
The cornerstone of management is anticoagulation, recommended for a defined minimum duration — even when the patient has no active symptoms. The choice of anticoagulant agent follows a specific evidence-based hierarchy, with certain oral agents preferred over others.
The complete regimen, agent selection criteria, and guidance on adjunct interventions are detailed in the full structured protocol.
Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.3949/ccjm.91a.22090

Proximal DVT is defined as thrombus in the popliteal, femoral, or iliac veins.

The 2021 CHEST guidelines recommend treating proximal DVT with anticoagulation for at least 3 months.

Proximal DVT confers up to a 50% risk of pulmonary embolism if left untreated, so treatment with anticoagulation is recommended even in the absence of symptoms ("incidental DVT").

The 2021 CHEST guidelines recommend the use of DOACs over warfarin whenever possible, based on data showing a lower risk of major bleeding (especially intracranial hemorrhage) with DOACs vs warfarin (strong recommendation with moderate-certainty evidence).

Use of an inferior vena cava filter should be considered only in patients deemed to have an unacceptably high bleeding risk.

View source ↗